Alport alloantibodies but not goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic α3(IV) collagen autoepitopes in vivo

Journal of Immunology

Volumn 185, Issue 6, 2010, Pages 3520-3528

  Luo, Wentian ^a   Wang, Xu Ping ^a   Kashtan, Clifford E ^a   Borza, Dorin Bogdan ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALPORT ALLOANTIBODY; AUTOANTIBODY; DIMER; EPITOPE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GOODPASTURE AUTOANTIBODY; MONOMER; TUMSTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CHEMICAL BOND; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROCESSING; SQUIRREL MONKEY;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; AUTOANTIGENS; BINDING SITES, ANTIBODY; COLLAGEN TYPE IV; CROSS REACTIONS; EPITOPES; GLOMERULONEPHRITIS; HUMANS; ISOANTIBODIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRITIS, HEREDITARY; PROTEIN STRUCTURE, TERTIARY;

EID: 78649831976     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001152     Document Type: Article

References (51)

1. Matsumoto, I., M. Maccioni, D. M. Lee, M. Maurice, B. Simmons, M. Brenner, D. Mathis, and C. Benoist. 2002. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3: 360-365.
2. Wipke, B. T., Z. Wang, J. Kim, T. J. McCarthy, and P. M. Allen. 2002. Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat. Immunol. 3: 366-372.
3. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
4. Borza, D. B., K. O. Netzer, A. Leinonen, P. Todd, J. Cervera, J. Saus, and B. G. Hudson. 2000. The goodpasture autoantigen: identification of multiple cryptic epitopes on the NC1 domain of the a3(IV) collagen chain. J. Biol. Chem. 275: 6030-6037.
5. Netzer, K. O., A. Leinonen, A. Boutaud, D. B. Borza, P. Todd, S. Gunwar, J. P. Langeveld, and B. G. Hudson. 1999. The Goodpasture autoantigen: mapping the major conformational epitope(s) of α3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J. Biol. Chem. 274: 11267-11274.
6. Hellmark, T., M. Segelmark, C. Unger, H. Burkhardt, J. Saus, and J. Wieslander. 1999. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int. 55: 936-944.
7. Yoshioka, K., A. F. Michael, J. Velosa, and A. J. Fish. 1985. Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes. Am. J. Pathol. 121: 156-165.
8. Wieslander, J., J. Langeveld, R. Butkowski, M. Jodlowski, M. Noelken, and B. G. Hudson. 1985. Physical and immunochemical studies of the globular domain of type IV collagen: cryptic properties of the Goodpasture antigen. J. Biol. Chem. 260: 8564-8570.
9. Borza, D. B., O. Bondar, P. Todd, M. Sundaramoorthy, Y. Sado, Y. Ninomiya, and B. G. Hudson. 2002. Quaternary organization of the Goodpasture autoantigen, the a3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the a4 and a5 NC1 domains. J. Biol. Chem. 277: 40075-40083.
10. Boutaud, A., D. B. Borza, O. Bondar, S. Gunwar, K. O. Netzer, N. Singh, Y. Ninomiya, Y. Sado, M. E. Noelken, and B. G. Hudson. 2000. Type IV collagen of the glomerular basement membrane: evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J. Biol. Chem. 275: 30716-30724.
11. Kang, J. S., S. Colon, T. Hellmark, Y. Sado, B. G. Hudson, and D. B. Borza. 2008. Identification of noncollagenous sites encoding specific interactions and quaternary assembly of α3α4α5(IV) collagen: implications for Alport gene therapy. J. Biol. Chem. 283: 35070-35077.
12. Vanacore, R. M., A. J. Ham, J. P. Cartailler, M. Sundaramoorthy, P. Todd, V. Pedchenko, Y. Sado, D. B. Borza, and B. G. Hudson. 2008. A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J. Biol. Chem. 283: 22737-22748.
13. David, M., D. B. Borza, A. Leinonen, J. M. Belmont, and B. G. Hudson. 2001. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen: a molecular basis for the cryptic nature of the epitope. J. Biol. Chem. 276: 6370-6377.
14. Borza, D. B., O. Bondar, S. Colon, P. Todd, Y. Sado, E. G. Neilson, and B. G. Hudson. 2005. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J. Biol. Chem. 280: 27147-27154.
15. Brainwood, D., C. Kashtan, M. C. Gubler, and A. N. Turner. 1998. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int. 53: 762-766.
16. Kalluri, R., A. Torre, C. F. Shield, III, E. D. Zamborsky, M. C. Werner, E. Suchin, G. Wolf, U. M. Helmchen, L. P. van den Heuvel, R. Grossman, et al. 2000. Identification of α3, α4, and α5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 69: 679-683.
17. Kang, J. S., C. E. Kashtan, A. N. Turner, L. Heidet, B. G. Hudson, and D. B. Borza. 2007. The alloantigenic sites of α3α4α5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the α5NC1 domain. J. Biol. Chem. 282: 10670-10677.
18. Wang, X. P., A. B. Fogo, S. Colon, G. Giannico, S. R. Abul-Ezz, J. H. Miner, and D. B. Borza. 2005. Distinct epitopes for anti-glomerular basement membrane Alport alloantibodies and Goodpasture autoantibodies within the noncollagenous domain of α3(IV) collagen: a Janus-faced antigen. J. Am. Soc. Nephrol. 16: 3563-3571.
19. Kashtan, C. E. 2006. Renal transplantation in patients with Alport syndrome. Pediatr. Transplant. 10: 651-657.
20. Lerner, R. A., R. J. Glassock, and F. J. Dixon. 1967. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J. Exp. Med. 126: 989-1004.
21. Edelstein, S. J. 1980. Patterns in the quinary structures of proteins: plasticity and inequivalence of individual molecules in helical arrays of sickle cell hemoglobin and tubulin. Biophys. J. 32: 347-360.
22. Vanacore, R., A. J. Ham, M. Voehler, C. R. Sanders, T. P. Conrads, T. D. Veenstra, K. B. Sharpless, P. E. Dawson, and B. G. Hudson. 2009. A sulfilimine bond identified in collagen IV. Science 325: 1230-1234.
23. -/- Alport mice. J. Am. Soc. Nephrol. 17: 1962-1969.
24. -/- Alport mice. Am. J. Pathol. 163: 1633-1644.
25. Nishie, W., D. Sawamura, M. Goto, K. Ito, A. Shibaki, J. R. McMillan, K. Sakai, H. Nakamura, E. Olasz, K. B. Yancey, et al. 2007. Humanization of autoantigen. Nat. Med. 13: 378-383.
26. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 379: 346-349.
27. Petkova, S. B., K. N. Konstantinov, T. J. Sproule, B. L. Lyons, M. A. Awwami, and D. C. Roopenian. 2006. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor FcγRIIB. J. Exp. Med. 203: 275-280.
28. Hudson, B. G., K. Tryggvason, M. Sundaramoorthy, and E. G. Neilson. 2003. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N. Engl. J. Med. 348: 2543-2556.
29. Borza, D. B., E. G. Neilson, and B. G. Hudson. 2003. Pathogenesis of Good-pasture syndrome: a molecular perspective. Semin. Nephrol. 23: 522-531.
30. Borza, D. B. 2007. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis. Nephron, Exp. Nephrol. 106: e37-e43.
31. Xiang, Z., A. J. Cutler, R. J. Brownlie, K. Fairfax, K. E. Lawlor, E. Severinson, E. U. Walker, R. A. Manz, D. M. Tarlinton, and K. G. Smith. 2007. FcγRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol. 8: 419-429.
32. Morgado, M. G., P. Cam, C. Gris-Liebe, P. A. Cazenave, and E. Jouvin-Marche. 1989. Further evidence that BALB/c and C57BL/6 γ2a genes originate from two distinct isotypes. EMBO J. 8: 3245-3251.
33. Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 310: 1510-1512.
34. Giorgini, A., H. J. Brown, H. R. Lock, F. Nimmerjahn, J. V. Ravetch, J. S. Verbeek, S. H. Sacks, and M. G. Robson. 2008. FcgRIII and FcγRIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J. Immunol. 181: 8745-8752.
35. Summers, S. A., O. M. Steinmetz, M. Li, J. Y. Kausman, T. Semple, K. L. Edgtton, D. B. Borza, H. Braley, S. R. Holdsworth, and A. R. Kitching. 2009. Th1 and Th17 cells induce proliferative glomerulonephritis. J. Am. Soc. Nephrol. 20: 2518-2524.
36. Nakamura, A., T. Yuasa, A. Ujike, M. Ono, T. Nukiwa, J. V. Ravetch, and T. Takai. 2000. Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J. Exp. Med. 191: 899-906.
37. Meyers, K. E., J. Allen, J. Gehret, A. Jacobovits, M. Gallo, E. G. Neilson, H. Hopfer, R. Kalluri, and M. P. Madaio. 2002. Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int. 61: 1666-1673.
38. Siebold, B., R. Deutzmann, and K. Kühn. 1988. The arrangement of intra- and intermolecular disulfide bonds in the carboxyterminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV collagen. Eur. J. Biochem. 176: 617-624.
39. Than, M. E., S. Henrich, R. Huber, A. Ries, K. Mann, K. Kühn, R. Timpl, G. P. Bourenkov, H. D. Bartunik, and W. Bode. 2002. The 1.9-Å crystal structure of the noncollagenous (NC1) domain of human placenta collagen IV shows stabilization via a novel type of covalent Met-Lys cross-link. Proc. Natl. Acad. Sci. USA 99: 6607-6612.
40. Vanacore, R. M., D. B. Friedman, A. J. Ham, M. Sundaramoorthy, and B. G. Hudson. 2005. Identification of S-hydroxylysyl-methionine as the covalent cross-link of the noncollagenous (NC1) hexamer of the α1α1α2 collagen IV network: a role for the post-translational modification of lysine 211 to hydroxylysine 211 in hexamer assembly. J. Biol. Chem. 280: 29300-29310.
41. Mamula, M. J., R. J. Gee, J. I. Elliott, A. Sette, S. Southwood, P. J. Jones, and P. R. Blier. 1999. Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins. J. Biol. Chem. 274: 22321-22327.
42. Doyle, H. A., and M. J. Mamula. 2001. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22: 443-449.
43. Anderton, S. M. 2004. Post-translational modifications of self antigens: implications for autoimmunity. Curr. Opin. Immunol. 16: 753-758.
44. Borza, C. M., D. B. Borza, V. Pedchenko, M. A. Saleem, P. W. Mathieson, Y. Sado, H. M. Hudson, A. Pozzi, J. Saus, D. R. Abrahamson, et al. 2008. Human podocytes adhere to the KRGDS motif of the a3a4a5 collagen IV network. J. Am. Soc. Nephrol. 19: 677-684.
45. Ryan, J. J., I. Katbamna, P. J. Mason, C. D. Pusey, and A. N. Turner. 1998. Sequence analysis of the "Goodpasture antigen" of mammals. Nephrol. Dial. Transplant. 13: 602-607.
46. Kalluri, R., T. M. Danoff, H. Okada, and E. G. Neilson. 1997. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J. Clin. Invest. 100: 2263-2275.
47. Kitching, A. R., A. L. Turner, T. Semple, M. Li, K. L. Edgtton, G. R. Wilson, J. R. Timoshanko, B. G. Hudson, and S. R. Holdsworth. 2004. Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-γ. J. Am. Soc. Nephrol. 15: 1764-1774.
48. Dean, E. G., G. R. Wilson, M. Li, K. L. Edgtton, K. M. O'Sullivan, B. G. Hudson, S. R. Holdsworth, and A. R. Kitching. 2005. Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int. 67: 566-575.
49. Hopfer, H., R. Maron, U. Butzmann, U. Helmchen, H. L. Weiner, and R. Kalluri. 2003. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J. 17: 860-868.
50. Weber, S., J. Engel, H. Wiedemann, R. W. Glanville, and R. Timpl. 1984. Subunit structure and assembly of the globular domain of basement-membrane collagen type IV. Eur. J. Biochem. 139: 401-410.
51. Borza, D. B., M. F. Chedid, S. Colon, D. J. Lager, N. Leung, and F. C. Fervenza. 2005. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-κ antibody autoreactive with the α1/α2 chains of type IV collagen. Am. J. Kidney Dis. 45: 397-406.